Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Eric, Ibsen"'
Autor:
Eric Ibsen
Publikováno v:
The Journal of Immunology. 208:173.01-173.01
A 2012 study published by Amgen researchers found that 90% of the in vivo oncology studies were not reproducible. Historically, 95% of post-phase III oncology clinical trial therapies failed to receive regulatory approval due to a lack of demonstrate
Autor:
Hannes Hentze, Eric Ibsen
Publikováno v:
Cancer Research. 79:90-90
Historically, a large majority of clinical phase III trials fail to gain regulatory approval due primarily to a lack of demonstrated efficacy, demonstrating the challenge of conducting clinically relevant efficacy studies in laboratory animals. In 20
Autor:
Eric Ibsen, Jeffrey L. Kumer
Publikováno v:
Cancer Research. 75:1555-1555
To more closely emulate clinical research methodology, researchers are increasingly utilizing clinically-similar group randomization and distribution methods for oncology studies in animals. It has been common practice to re-house animals into new ca
Autor:
Vinay, Bhaskar, Debbie A, Law, Eric, Ibsen, Danna, Breinberg, Kellie M, Cass, Robert B, DuBridge, Ferdinand, Evangelista, Susan M, Henshall, Peter, Hevezi, Jennifer C, Miller, Melody, Pong, Rick, Powers, Peter, Senter, David, Stockett, Robert L, Sutherland, Ursula, von Freeden-Jeffry, Dorian, Willhite, Richard, Murray, Daniel E H, Afar, Vanitha, Ramakrishnan
Publikováno v:
Cancer research. 63(19)
We have used the Eos Hu03 GeneChip array, which represents over 92% of the transcribed human genome, to measure gene expression in a panel of normal and diseased human tissues. This analysis revealed that E-selectin mRNA is selectively overexpressed
Autor:
Eric Ibsen, Jeffrey L. Kumer
Publikováno v:
Cancer Research. 74:3498-3498
The use of software applications to automate the workflow specific to preclinical oncology trials can significantly improve labor efficiency, data quality & security while preserving both methodology and results in a searchable database in perpetuity
Publikováno v:
Cancer Research. 74:4190-4190
To more closely emulate clinical research methodology and improve clinical relevance, researchers are increasingly utilizing clinically-similar group randomization and distribution methods for oncology studies in animals. One common pre-clinical appr
Autor:
Eric Ibsen, Jeff Kumer
Publikováno v:
The Journal of Immunology. 192:49.8-49.8
To more closely emulate clinical research methodology and improve clinical relevance, researchers are increasingly utilizing more clinically-similar group randomization and distribution methods for Inflammation studies in animals. A common pre-clinic
Autor:
Jeffrey Kumer, Eric Ibsen
Publikováno v:
The FASEB Journal. 28:1053.7
To closely emulate clinical research methodology and improving clinical relevance, researchers are utilizing clinically-similar group randomization and distribution methods for pre-clinical studies...
Autor:
Eric Ibsen
Publikováno v:
Clinical Immunology. 131:S79-S80
Autor:
Jeff Kumer, Eric Ibsen
Publikováno v:
The Journal of Immunology. 188:124.16-124.16
The traditional management of immunological animal studies and results is challenging due to complex, varied workflows as well as the acquisition, analysis, secure storage and accessibility of disparate data types acquired and stored in multiple form